outperform price
chang recommend
upgrad outperform less bad short
continu believ dental result ugli across
board correspond ebit impact current
situat improv vs week ago dental volum
trend better prior expect dental volum
current normal vs earli april addit
consum seem view return dentist posit
light vs activ compromis social distanc point
room volum improv cours
recoveri beyond well posit vs mani dental
peer premium franchis mani key product area well
strong liquid help gain share vs peer
well present consolid opportun
ada survey data better fear help de-risk downsid
acknowledg forecast impact pandem
inexact scienc say least ada survey data continu
trend better expect post earn click
link survey data caus us rais revenu
estim particularli consum see less
impact vs equipment/wil bounc back quickli
less squeamish dentist post covid
mani investor spoken express hesit
return dentist post-covid non-emerg
procedur would count hesit camp well
larg survey point higher degre comfort vs mani re-
open activ basic except go nation park
point continu growth patient volum go forward
might time peopl will go
dentist vs hug friend
valuat still reason solid post-covid posit
admittedli wish written note last week
still howev new price target still
well valuat level revenu vs forward
forward ebitda vs forward
reason provid cushion addit
benefit go forward premium franchis
mani key product area strong manag control cost
enviabl liquid posit wit last night mm senior
note benefit current
environ also like post-covid dental industri
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
dental volum rapidli increas past month
almost dental practic open doubl week
week
open busi usual
close see
week
consum like go dentist vs hug friend
fli
go
go
beach
go routin
checkup
beyond current covid environ also rais xray revenu estim given
shallow covid impact vs prior expect share gain vs smaller competitor less robust product
offer weaker financ
last night rais mm interest rate add mm run rate basi
interest cost send strong signal regard compani overal liquid posit given fragment natur
dental manufactur industri would view consolid post-covid shake mani
manufactur strap financ like hold valuat recent run rev
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk includ slowdown global dental market failur restructur busi hit manag long-term
articl articl
time dissemin may pm et
analyst elizabeth anderson amato primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
